Adding AKT Inhibitor Shows Benefit in PTEN-Deficient Prostate Cancer

Adding AKT Inhibitor Shows Benefit in PTEN-Deficient Prostate Cancer

The addition of the AKT inhibitor capivasertib (Truqap) to abiraterone (Zytiga) and androgen deprivation therapy (ADT) improved radiographic progression-free survival (rPFS) in patients with PTEN-deficient metastatic hormone-sensitive prostate cancer in the phase III CAPItello-281 study presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium. In this exclusive MedPage Today video, Daniel J. George,…

Read More
Scores Sick After Toxic Chocolate; Lethal Ants Spread; $250M Hospice Fraud Scheme

Scores Sick After Toxic Chocolate; Lethal Ants Spread; $250M Hospice Fraud Scheme

Note that some links may require registration or subscription. CDC researchers catalogued 180 cases of severe illness across more than 30 states among people who ate Diamond Shruumz and other mushroom-containing chocolate in 2024; nearly one-fourth required intensive care and two people died. (Morbidity and Mortality Weekly Report) The U.S. birth rate declined by 1%…

Read More